Related Experiment Videos

[Vancomycin resistant enterococcal infections and detection of their resistance genes]

Naohisa Fujita1

  • 1Department of Clinical and Laboratory Medicine, Kyoto Prefectural University of Medicine.

Rinsho Byori. the Japanese Journal of Clinical Pathology
|March 26, 2003
PubMed

Insights

Vancomycin-resistant enterococci (VRE) are significant nosocomial pathogens. Detecting VRE resistance genes via PCR is essential for accurate identification and clinical management.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Diagnostics

Context:

  • Vancomycin-resistant enterococci (VRE) are a major cause of hospital-acquired infections globally.
  • VRE infections primarily affect immunocompromised patients and those undergoing antimicrobial therapy.
  • VRE strains are classified into six types based on resistance genes, with VanA and VanB types being clinically significant.

Purpose:

  • To highlight the clinical importance of VanA and VanB type VRE.
  • To discuss the utility of susceptibility testing for differentiating VanA and VanB types.
  • To emphasize the necessity of PCR for definitive VRE identification.

Summary:

  • VRE poses a significant threat in healthcare settings worldwide.
  • Phenotypic screening using vancomycin (VCM) and teicoplanin (TEIC) aids in differentiating VanA and VanB VRE types.
  • Polymerase chain reaction (PCR) offers a straightforward and crucial method for confirming VRE resistance gene detection.

Impact:

  • Improved diagnostic strategies for VRE infections.
  • Enhanced understanding of VRE epidemiology and resistance mechanisms.
  • Facilitation of targeted antimicrobial therapy and infection control measures.

Related Concept Videos